Connect with us

Health

An Effective Treatment for Opioid Addiction Exists. Why Isn’t It Used More?

Published

on

An Effective Treatment for Opioid Addiction Exists. Why Isn’t It Used More?

Then, in November, with the election of Donald Trump and the Republicans’ return to power in Congress, the question of how best to respond to opioid-use disorder was confronted with new uncertainty. For the past decade, the push to expand access to treatment for opioid addiction has enjoyed bipartisan support. But during his campaign, Trump outlined a draconian vision to address the opioid problem, threatening drug dealers and smugglers with the death penalty and promising to “seal” the border. On Feb. 1, he signed an executive order to levy tariffs against China, Mexico and Canada, in part to pressure these countries to halt the flow of fentanyl into the United States. (Soon after, he gave 30-day reprieves to Canada and Mexico.)

Keith Humphreys, a professor of psychiatry and behavioral sciences at Stanford who studies the opioid crisis, says the idea that beefed-up border control could halt or greatly curtail the flow of fentanyl into the country is simply misguided. Fentanyl is so concentrated that the amount needed to supply the entire country’s demand for a year is at most 10 metric tons, he estimates. Law enforcement has to find those 10 tons — the weight of few cars — among the more than seven million trucks carrying goods that cross the border annually. To meaningfully impede the flow of fentanyl, he thinks, you would have to completely close the border, at which point the country would inflict massive economic harm on itself. And even with the border shut, drones, planes and tunnels can easily continue supplying the market. A birthday-card-size letter mailed from abroad could carry a week’s supply of the opioid for someone. “You can’t really keep fentanyl out of such a big country,” he says.

Trump’s expressed desire to slash government spending also worries proponents of medication-for-addiction treatment. Some Republicans are actively seeking ways to cut Medicaid, along with other federal programs. Trump may also try to undo or simply undermine the Affordable Care Act, a favorite target. Either development could be disastrous for the distribution of medication to treat opioid addiction, reversing the gains, however tenuous, made under the Biden administration. Medicaid covers an estimated 40 percent of non-elderly adults with opioid-use disorder in the United States, some two-thirds of whom receive treatment for their addiction through the program.

It’s also possible, however, that Trump will expand the public-health approach he embraced during his first term, which was furthered by the Biden administration, and continue to encourage efforts to roll out M.A.T. Trump signed a law during his first term that removed some requirements for doctors who wanted to prescribe buprenorphine, notes Kassandra Frederique, the executive director of Drug Policy Alliance, a nonprofit that advocates for less-punitive drug policy. And uniquely among Republican presidents, Trump supported the use of some harm-reduction practices like making clean syringes available, according to his first-term surgeon general. Frederique told me she hopes that the current administration will continue to build on the work Trump and others have done to expand access to treatment.

What’s important to remember is just how much evidence exists indicating that buprenorphine can help people with opioid addiction. Sarah Wakeman often points this out as she pushes back against what she sees as a pervasive sense of pessimism around the opioid crisis. The problem is that this medicine isn’t getting to the people who need it quickly enough. “Most people think this is a terribly recalcitrant, untreatable, insurmountable problem,” she says. “That couldn’t be further from the truth.”

Advertisement

Health

Wegovy Pill Side Effects To Watch for and How It Compares to Injections

Published

on

Wegovy Pill Side Effects To Watch for and How It Compares to Injections


Advertisement





Wegovy Pill Side Effects To Watch for and How To Minimize Them




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Parkinson’s risk increases with exposure to common chemical, study suggests

Published

on

Parkinson’s risk increases with exposure to common chemical, study suggests

NEWYou can now listen to Fox News articles!

A pesticide commonly used in America’s food supply has been linked to Parkinson’s disease, new research suggests.

A UCLA study published in the journal Springer Nature Link suggests that exposure to chlorpyrifos could increase the risk of the neurological disease.

The chemical is often used on agricultural products like soybeans, fruit and nut trees, broccoli, cauliflower and other row crops, according to the U.S. Environmental Protection Agency.

EARLY PARKINSON’S COULD BE DETECTED DECADES BEFORE SYMPTOMS WITH SIMPLE BLOOD TEST

Advertisement

The study compared 829 people with Parkinson’s to 824 people without the disease over a 45-year period, focusing on their proximity to chlorpyrifos.

The researchers also conducted mouse experiments, where mice inhaled the pesticide as humans would for 11 weeks. Experiments were also carried out on zebrafish to study cell-level brain damage.

Chlorpyrifos is often used on agricultural products like soybeans, fruit and nut trees, broccoli, cauliflower and other row crops, according to the U.S. Environmental Protection Agency. (iStock)

In humans, the study revealed that long-term exposure to chlorpyrifos led to more than a 2.5 times higher risk of Parkinson’s.

In mice, exposure to the pesticide caused movement problems similar to Parkinson’s symptoms, loss of dopamine-producing neurons, increased brain inflammation and build-up of harmful proteins.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Zebrafish suffered brain cell death and damage linked to failure in the cell’s “cleanup system,” according to the study press release.

Dr. Jeff Bronstein, director of the Movement Disorders Program at UCLA and professor of neurology and molecular toxicology, noted that previous human studies also suggested an association between chlorpyrifos exposure and Parkinson’s.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“[We were] surprised that the mechanism of toxicity was apparent in both mice and zebrafish,” he said. “We rarely find such consistent results in different animal models.”

Advertisement

A researcher commented that the consistency in results between human and animal subjects is “rare.” (iStock)

The researcher emphasized that the association between pesticide exposure and Parkinson’s was “very strong,” and the longer someone was exposed, the higher the risk became.

“People should avoid exposure to CPF and similar pesticides (organophosphates) by not using them in their home, eating organics, and washing fruits and vegetables before eating them,” Bronstein advised.

Study limitations

The study did have some limitations, the researchers acknowledged, primarily that it was observational, meaning it shows an association but cannot prove causation.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

It also estimated exposure based on participants’ locations, and did not measure diet, indoor exposure or personal lifestyle behaviors. Additionally, the results of the animal models can’t be translated directly to humans.

There was also the possibility that chlorpyrifos was used along with other chemicals, which means it could be difficult to measure its specific impact, the study noted.

Chlorpyrifos is used to control different kinds of pests, like termites, mosquitoes and roundworms, among crops. (iStock)

Industry reaction

Chlorpyrifos is used to control different kinds of pests, like termites, mosquitoes and roundworms, among crops, according to the National Pesticide Information Center (NPIC) at Oregon State University.

People can be exposed to the pesticide by breathing it in or by consuming contaminated food or water.

Advertisement

In 2021, the EPA banned the use of chlorpyrifos on food crops, but a federal appeals court overturned that decision in 2023, allowing its use to resume on some crops while regulators revisit the rule.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

In January 2026, the EPA issued an update outlining plans to move forward with a rule that would ban most uses of chlorpyrifos.

“Chlorpyrifos is subject to registration review, a process required under FIFRA (the Federal Insecticide, Fungicide, and Rodenticide Act) in which registered pesticides are comprehensively evaluated every 15 years against current safety standards and the latest scientific evidence,” the EPA said in a statement sent to Fox News Digital.

“EPA is currently developing a revised human health risk assessment for chlorpyrifos as part of that review, and will consider this study alongside any other relevant submissions,” the agency said in a statement sent to Fox News Digital. (Getty)

Advertisement

“EPA is currently developing a revised human health risk assessment for chlorpyrifos as part of that review, and will consider this study alongside any other relevant submissions. Where the science calls for stronger protections or tolerance revocations, EPA will act without hesitation and without delay.”

Fox News Digital reached out to several manufacturers of the chemical for comment.

“People should avoid exposure to CPF and similar pesticides.”

Corteva, an Indiana agrichemical company formed in 2019 through the merger of Dow Chemical and DuPont, announced in 2020 that it would end production of chlorpyrifos within the year, citing declining sales.

In April 2022, the German chemical company BASF requested the cancellation of its pesticide registrations for products containing chlorpyrifos. 

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“BASF does not manufacture chlorpyrifos and does not have any pesticide registrations issued by the U.S. EPA for chlorpyrifos-containing products,” the company told Fox News Digital. 

No products from Corteva or BASF were included in the study linking chlorpyrifos to Parkinson’s disease.

Continue Reading

Health

‘Call a Boomer’ payphones help cure loneliness, spark friendships across generations

Published

on

‘Call a Boomer’ payphones help cure loneliness, spark friendships across generations

NEWYou can now listen to Fox News articles!

Along a bustling sidewalk in Boston, a bright yellow payphone invites folks to “call a Boomer.”

Almost 3,000 miles away in Reno, Nevada, a nearly identical phone prompts residents of Sierra Manor – an apartment complex for seniors – to “Call a Zoomer.” The goal is simple: to get strangers to talk to each other.

The project, often referred to as simply “Call a Boomer,” is the latest initiative from Matter Neuroscience, a New York-based company dedicated to mapping the “biomarkers of happiness.”

NEARLY HALF OF SENIORS IMPROVE WITH AGE — AND RESEARCHERS THINK THEY KNOW WHY

Advertisement

By connecting “two of the loneliest demographics” (older adults and younger adults), the project aims to prove that on a molecular level, “humans need one another in order to be happy,” according to Calla Kessler, a social strategist at Matter Neuroscience.

Along a bustling sidewalk in Boston, a bright yellow payphone invites folks to “Call a Boomer.” (Matter Neuroscience)

“Younger adults and older adults tend to experience the highest levels of loneliness of any age group,” the company wrote on its website. “So the goal of this project is to inspire generational connection through meaningful conversations, despite differences in age, lifestyle or politics.”

GRANDPARENTS WHO BABYSIT THEIR GRANDCHILDREN STAY MENTALLY SHARPER, NEW STUDY REVEALS

The hope, according to Kessler, is that the calls will shift the brain’s focus from stress to bonding.

Advertisement

“Our neuroscience angle is cannabinoids over cortisol,” Kessler told Fox News Digital. “Cannabinoids are the feel-good neurotransmitter in our brain that creates that warm feeling with a friendship — and when you activate cannabinoids, you’re counteracting the negative effects of cortisol, which is our primary stress hormone.”

“Younger adults and older adults tend to experience the highest levels of loneliness of any age group,” the company noted. (Matter Neuroscience)

This isn’t Matter’s first round of payphones. Its initial experiment connected one of the most liberal cities in the U.S. (San Francisco) with one of the most conservative (Abilene, Texas).

“We basically just wanted people to find common ground and encourage people to think beyond labels,” Kessler said.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

She noted that the negative results were “almost negligible,” with most participants enjoying their time speaking to different people.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Now, the focus has shifted from political labels to generational divides.

The negative results have beem “almost negligible,” with most participants enjoying their time speaking to different people. (Matter Neuroscience)

As the “Call a Boomer” experiment continues, the team is busy collecting audio files of these intergenerational chats to prove that simple connections with other humans can help improve mental health.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“Our research is essentially trying to find a non-pharmaceutical cure to depression,” Kessler added.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Looking ahead, she said, “we’ll definitely be doing fun things that we hope get people’s attention and inspire them to learn a little more about themselves.”

Advertisement
Continue Reading

Trending